Selumetinib in pediatric patients with non-neurofibromatosis type 1-associated, nonoptic pathway (OPG) and non-pilocytic recurrent/ progressive low-grade glioma harboring BRAFV600E mutation or BRAF-KIAA1549 fusion: A multicenter prospective Pediatric Brain Tumor Consortium (PBTC) phase 2 trial Meeting Abstract


Authors: Fangusaro, J.; Onar-Thomas, A.; Poussaint, T. Y.; Lensing, S.; Wu, S.; Ligon, A. H.; Lindeman, N.; Stewart, C. F.; Jones, D. T. W.; Pfister, S. M.; Smiley, N. P.; Leach, J.; Packer, R.; Vezina, G.; Lenzen, A.; Jaju, A.; Goldman, S.; Doyle, L. A.; Smith, M.; Fouladi, M.; Dunkel, I.
Abstract Title: Selumetinib in pediatric patients with non-neurofibromatosis type 1-associated, nonoptic pathway (OPG) and non-pilocytic recurrent/ progressive low-grade glioma harboring BRAFV600E mutation or BRAF-KIAA1549 fusion: A multicenter prospective Pediatric Brain Tumor Consortium (PBTC) phase 2 trial
Meeting Title: 20th International Symposium on Pediatric Neuro-Oncology (ISPNO 2022)
Journal Title: Neuro-Oncology
Volume: 24
Issue: Suppl. 1
Meeting Dates: 2022 Jun 12-15
Meeting Location: Hamburg, Germany
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2022-06-01
Start Page: i88
Language: English
ACCESSION: WOS:000840122400325
PROVIDER: wos
DOI: 10.1093/neuonc/noac079.322
Notes: Meeting Abstract: LGG-06 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    372 Dunkel